MULATERO, Paolo
MULATERO, Paolo
SCIENZE MEDICHE
10 good reasons why adrenal vein sampling is the preferred method for referring primary aldosteronism patients for adrenalectomy
2019-01-01 Rossi G.P.; Mulatero P.; Satoh F.
11beta-Hydroxysteroid dehydrogenase type 2 activity is associated with left ventricular mass in essential hypertension.
2005-01-01 N. GLORIOSO; F. FILIGHEDDU; PP. PARPAGLIA; A. SORO; C. TROFFA; G. ARGIOLAS; P. MULATERO
18-Hydroxycorticosterone, 18-Hydroxycortisol, and 18-Oxocortisol in the Diagnosis of Primary Aldosteronism and Its Subtypes
2012-01-01 Mulatero P; Morra di Cella S; Monticone S; Schiavone D; Manzo M; Mengozzi G; Rabbia F; Terzolo M; Gomez-Sanchez EP; Gomez-Sanchez CE; Veglio F.
1α,25-Dihydroxyvitamin D3 inhibits the human H295R cell proliferation by cell cycle arrest: A model for a protective role of vitamin D receptor against adrenocortical cancer
2014-01-01 Catia Pilon;Riccardo Urbanet;Tracy A. Williams;Takashi Maekawa;Silvia Vettore;Rosa Sirianni;Vincenzo Pezzi;Paolo Mulatero;Ambrogio Fassina;Hironobu Sasano;Francesco Fallo
[Assessment of cardiovascular risk in hypertensive patients: comparison among scores]
2004-01-01 DEL COLLE S; RABBIA F; MULATERO P; VEGLIO F
[Primary dexamethasone-suppressible hyperaldosteronism and hyperprolactinemia]
1992-01-01 VEGLIO F ;PINNA G ;RABBIA F ;MULATERO P ;CHIANDUSSI L
[Role of aldosterone in the metabolic syndrome.]
2006-01-01 MULATERO P; BERTELLO C; VERHOVEZ A; TESTA E; PUGLISI E; MORELLO F; MONTICONE S; FALLO F; VEGLIO F
[The L-arginine/nitric oxide metabolic pathway. Its physiopathology and clinical implications]
1996-01-01 MENGOZZI G ;VEGLIO F ;SCHIAVONE D ;INCONIS T ;MULATERO P ;PARADISI L
A case of adrenal vein sampling in primary aldosteronism with homolateral suppression
2017-01-01 Viola A.; Monticone S.; Rossato D.; Versace K.; Castellano I.; Burrello J.; Buffolo F.; Veglio F.; Mulatero P.
A case of severe hyperaldosteronism caused by a de novo mutation affecting a critical salt bridge kir3.4 residue.
2015-01-01 Monticone S; Bandulik S; Stindl J; Zilbermint M; Dedov I; Mulatero P; Allgaeuer M; Lee CC; Stratakis CA; Williams TA; Tiulpakov A.
A new form of hereditary primary aldosteronism: familial hyperaldosteronism type III
2008-01-01 Mulatero P
A Novel Y152C KCNJ5 Mutation Responsible for Familial Hyperaldosteronism Type III
2013-01-01 S. Monticone;N. G. Hattangady;D. Penton;C. M. Isales;M. A. Edwards;T. A. Williams;C. Sterner;R. Warth;P. Mulatero;W. E. Rainey
A particular phenotype in a girl with aldosterone synthase deficiency
2004-01-01 T.A. WILLIAMS; P. MULATERO; M. BOSIO; S. LEWICKA; M. PALERMO; F. VEGLIO; D. ARMANINI
A simple UHPLC-PDA method with a fast dilute-and-shot sample preparation for the quantification of canrenone and its prodrug spironolactone in human urine samples
2018-01-01 Avataneo, Valeria; De Nicolò, Amedeo; Rabbia, Franco; Sciandra, Mauro; Tosello, Francesco; Cusato, Jessica; Perlo, Elisa; Fatiguso, Giovanna; Allegra, Sarah; Favata, Fabio; Mulatero, Paolo; Veglio, Franco; Di Perri, Giovanni; D'Avolio, Antonio
A time-resolved fluoroimmunoassay for 18-oxocortisol and 18-hydroxycortisol. Development of a monoclonal antibody to 18-oxocortisol.
2002-01-01 S. MORRA DI CELLA; F. VEGLIO; P.MULATERO; V.CHRISTENSEN; K.AYCOCK; ZHENG ZHU; E.P. GOMEZ-SANCHEZ; C. E.GOMEZ-SANCHEZ.
Absence of D147E mutation of CYP11B2 gene in hypertensive patients with increased corticosterone and aldosterone production.
2001-01-01 P.MULATERO; N.GLORIOSO; F.FALLO; A.SORO; S.MORRA DI CELLA; R.CARRA; F.FILIGHEDDU; F. VEGLIO
Adiponectin and insulin sensitivity in primary aldosteronism.
2007-01-01 FALLO F; DELLA MEA P; SONINO N; BERTELLO C; ERMANI M; VETTOR R; F. VEGLIO; MULATERO P
Adrenal endothelin-1 levels are not associated with aldosterone secretion in primary aldosteronism
2009-01-01 Morello F; Schiavone D; Mengozzi G; Bertello C; Liew CC; Bisbocci D; Mulatero P; Veglio F.
Adrenal surgery for bilateral primary aldosteronism: an international retrospective cohort study
2022-01-01 Williams, Tracy Ann; Gong, Siyuan; Tsurutani, Yuya; Tezuka, Yuta; Thuzar, Moe; Burrello, Jacopo; Wu, Vin-Cent; Yamazaki, Yuto; Mulatero, Paolo; Sasano, Hironobu; Stowasser, Michael; Nishikawa, Tetsuo; Satoh, Fumitoshi; Reincke, Martin
Adrenal vein sampling in primary aldosteronism: towards a standardised protocol.
2015-01-01 Monticone, S; Viola, A; Rossato, D; Veglio, F; Reincke, M; Gomez-Sanchez, C; Mulatero, P
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
10 good reasons why adrenal vein sampling is the preferred method for referring primary aldosteronism patients for adrenalectomy | 2019 | Rossi G.P.; Mulatero P.; Satoh F. | |
11beta-Hydroxysteroid dehydrogenase type 2 activity is associated with left ventricular mass in essential hypertension. | 2005 | N. GLORIOSO; F. FILIGHEDDU; PP. PARPAGLIA; A. SORO; C. TROFFA; G. ARGIOLAS; P. MULATERO | |
18-Hydroxycorticosterone, 18-Hydroxycortisol, and 18-Oxocortisol in the Diagnosis of Primary Aldosteronism and Its Subtypes | 2012 | Mulatero P; Morra di Cella S; Monticone S; Schiavone D; Manzo M; Mengozzi G; Rabbia F; Terzolo M; Gomez-Sanchez EP; Gomez-Sanchez CE; Veglio F. | |
1α,25-Dihydroxyvitamin D3 inhibits the human H295R cell proliferation by cell cycle arrest: A model for a protective role of vitamin D receptor against adrenocortical cancer | 2014 | Catia Pilon;Riccardo Urbanet;Tracy A. Williams;Takashi Maekawa;Silvia Vettore;Rosa Sirianni;Vincenzo Pezzi;Paolo Mulatero;Ambrogio Fassina;Hironobu Sasano;Francesco Fallo | |
[Assessment of cardiovascular risk in hypertensive patients: comparison among scores] | 2004 | DEL COLLE S; RABBIA F; MULATERO P; VEGLIO F | |
[Primary dexamethasone-suppressible hyperaldosteronism and hyperprolactinemia] | 1992 | VEGLIO F ;PINNA G ;RABBIA F ;MULATERO P ;CHIANDUSSI L | |
[Role of aldosterone in the metabolic syndrome.] | 2006 | MULATERO P; BERTELLO C; VERHOVEZ A; TESTA E; PUGLISI E; MORELLO F; MONTICONE S; FALLO F; VEGLIO F | |
[The L-arginine/nitric oxide metabolic pathway. Its physiopathology and clinical implications] | 1996 | MENGOZZI G ;VEGLIO F ;SCHIAVONE D ;INCONIS T ;MULATERO P ;PARADISI L | |
A case of adrenal vein sampling in primary aldosteronism with homolateral suppression | 2017 | Viola A.; Monticone S.; Rossato D.; Versace K.; Castellano I.; Burrello J.; Buffolo F.; Veglio F.; Mulatero P. | |
A case of severe hyperaldosteronism caused by a de novo mutation affecting a critical salt bridge kir3.4 residue. | 2015 | Monticone S; Bandulik S; Stindl J; Zilbermint M; Dedov I; Mulatero P; Allgaeuer M; Lee CC; Stratakis CA; Williams TA; Tiulpakov A. | |
A new form of hereditary primary aldosteronism: familial hyperaldosteronism type III | 2008 | Mulatero P | |
A Novel Y152C KCNJ5 Mutation Responsible for Familial Hyperaldosteronism Type III | 2013 | S. Monticone;N. G. Hattangady;D. Penton;C. M. Isales;M. A. Edwards;T. A. Williams;C. Sterner;R. Warth;P. Mulatero;W. E. Rainey | |
A particular phenotype in a girl with aldosterone synthase deficiency | 2004 | T.A. WILLIAMS; P. MULATERO; M. BOSIO; S. LEWICKA; M. PALERMO; F. VEGLIO; D. ARMANINI | |
A simple UHPLC-PDA method with a fast dilute-and-shot sample preparation for the quantification of canrenone and its prodrug spironolactone in human urine samples | 2018 | Avataneo, Valeria; De Nicolò, Amedeo; Rabbia, Franco; Sciandra, Mauro; Tosello, Francesco; Cusato, Jessica; Perlo, Elisa; Fatiguso, Giovanna; Allegra, Sarah; Favata, Fabio; Mulatero, Paolo; Veglio, Franco; Di Perri, Giovanni; D'Avolio, Antonio | |
A time-resolved fluoroimmunoassay for 18-oxocortisol and 18-hydroxycortisol. Development of a monoclonal antibody to 18-oxocortisol. | 2002 | S. MORRA DI CELLA; F. VEGLIO; P.MULATERO; V.CHRISTENSEN; K.AYCOCK; ZHENG ZHU; E.P. GOMEZ-SANCHEZ; C. E.GOMEZ-SANCHEZ. | |
Absence of D147E mutation of CYP11B2 gene in hypertensive patients with increased corticosterone and aldosterone production. | 2001 | P.MULATERO; N.GLORIOSO; F.FALLO; A.SORO; S.MORRA DI CELLA; R.CARRA; F.FILIGHEDDU; F. VEGLIO | |
Adiponectin and insulin sensitivity in primary aldosteronism. | 2007 | FALLO F; DELLA MEA P; SONINO N; BERTELLO C; ERMANI M; VETTOR R; F. VEGLIO; MULATERO P | |
Adrenal endothelin-1 levels are not associated with aldosterone secretion in primary aldosteronism | 2009 | Morello F; Schiavone D; Mengozzi G; Bertello C; Liew CC; Bisbocci D; Mulatero P; Veglio F. | |
Adrenal surgery for bilateral primary aldosteronism: an international retrospective cohort study | 2022 | Williams, Tracy Ann; Gong, Siyuan; Tsurutani, Yuya; Tezuka, Yuta; Thuzar, Moe; Burrello, Jacopo; Wu, Vin-Cent; Yamazaki, Yuto; Mulatero, Paolo; Sasano, Hironobu; Stowasser, Michael; Nishikawa, Tetsuo; Satoh, Fumitoshi; Reincke, Martin | |
Adrenal vein sampling in primary aldosteronism: towards a standardised protocol. | 2015 | Monticone, S; Viola, A; Rossato, D; Veglio, F; Reincke, M; Gomez-Sanchez, C; Mulatero, P |